Lower-Cost Alternative for High-Performance AlphaScreen® Detection from BioTek Instruments
April 11, 2008
The superior optical design of both Synergy™ 2 and Synergy 4 multi-mode microplate readers allows for large measurement bandwidths with low levels of signal for highly accurate results.
“Synergy multi-mode microplate readers offer researchers a lower-cost alternative to costly high-end HTS readers while providing the same high levels of quality and performance,” noted Xavier Amouretti, BioTek Product Manager. “Compatibility with the AlphaScreen assay platform is just one example of how we deliver powerful yet cost-effective solutions for users.”
Synergy 2 uses a combination of detection modes for high-performance in Fluorescence Intensity, Fluorescence Polarization, Time-Resolved Fluorescence, Luminescence and UV-visible Absorbance.
The patent-pending Synergy™ 4, Hybrid Microplate Reader, is the first multi-mode reader to combine filter-based and quadruple monochromator-based fluorescence detection technology to perform an endless number of current and future microplate-based assays. Synergy 4 also includes Fluorescence Intensity, Luminescence, Fluorescence Polarization, Time-Resolved Fluorescence, and UV-Visible Absorbance.
BioTek Instruments, Inc., headquartered in Winooski, VT, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to accelerate the drug discovery process, to advance discoveries in genomics and proteomics, and to aid in the advancement of life science research.
AlphaScreen is a registered trademark of PerkinElmer, Inc.
For further information, contact:
Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications